Alcoholism: all 1,634 studies

Page 6 of 17. Open to participants first (329), then studies with results posted, then the rest; newest registration first within each.

• Combining Varenicline and Naltrexone for Smoking CessationCompletedNCT02698215Phase 2Results posted
• Smartphone Based Continuing Care for AlcoholCompletedNCT02681406Not applicableResults posted
• A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male SubjectsCompletedNCT02679469Phase 1Results posted
• Sustaining Patient-centered Alcohol-related CareCompletedNCT02675777Not applicableResults posted
• Treatment Engagement With Technology-assisted TreatmentCompletedNCT02674477Not applicableResults posted
• Cognitive Training in the Treatment of AUDCompletedNCT02664038Not applicableResults posted
• Ketamine for Reduction of Alcoholic RelapseCompletedNCT02649231Phase 2Results posted
• Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication TrialCompletedNCT02646449Phase 2Results posted
• Clinical Medication Development for Bipolar Disorder and Alcohol Use DisordersCompletedNCT02582905Phase 4Results posted
• Project IMPACT: In-the-Moment Protection From Automatic Capture by TriggerCompletedNCT02579317Not applicableResults posted
• Glutamatergic Modulation of Disordered Alcohol UseCompletedNCT02539511Phase 2/3Results posted
• Serotonin Selective Reuptake Inhibitor Treatment of Dual Diagnosis Post-traumatic Stress Disorder and Alcohol ProblemsCompletedNCT02504931Phase 4Results posted
• CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use DisordersCompletedNCT02500602Phase 2Results posted
• Alcohol Disorder hOsPital Treatment TrialCompletedNCT02478489Phase 4Results posted
• Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use DisorderCompletedNCT02461927Phase 1/2Results posted
• Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department UsersCompletedNCT02445339Phase 4Results posted
• Carisbamate as a Potential Treatment for Alcohol DependenceCompletedNCT02435381Phase 1/2Results posted
• A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol DependenceCompletedNCT02382276Phase 3Results posted
• A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy DrinkersCompletedNCT02371889Phase 2Results posted
• Effectiveness of Zonisamide in Alcohol Dependent VeteransTerminatedNCT02368431Phase 3Results posted
• A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)CompletedNCT02364947Phase 3Results posted
• Pharmacogenetic Study of Ondansetron in Alcohol Use DisorderCompletedNCT02354703Phase 2Results posted
• Gabapentin for Alcohol Relapse PreventionCompletedNCT02349477Phase 2Results posted
• Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use DisordersCompletedNCT02322047Phase 2Results posted
• Oxytocin Treatment of Alcohol DependenceCompletedNCT02275611Phase 2Results posted
• HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use DisorderCompletedNCT02252536Phase 2Results posted
• Oxytocin Treatment of Alcohol DependenceCompletedNCT02251912Phase 2Results posted
• Mifepristone for the Prevention of Relapses of Alcohol DrinkingCompletedNCT02243709Phase 1/2Results posted
• Group Motivational Interviewing (GMI) For Homeless Veterans In VA ServicesCompletedNCT02233738Not applicableResults posted
• Alcohol Screening, Brief Intervention, and Referral to Treatment in a Military Treatment FacilityCompletedNCT02228967Not applicableResults posted
• Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSDCompletedNCT02226367Not applicableResults posted
• Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and DependenceCompletedNCT02210195Phase 2Results posted
• Progesterone Effect on Individuals Diagnoses With AD and PTSD.CompletedNCT02187224Phase 2/3Results posted
• Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.CompletedNCT02185131Phase 2Results posted
• Mifepristone Treatment of Alcohol Use DisorderCompletedNCT02179749Phase 2Results posted
• Clinical Intervention in Alcohol Use DisorderCompletedNCT02168400Not applicableResults posted
• A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use DisorderCompletedNCT02161718Phase 2Results posted
• Study of Mobile Phone Delivered Intervention to Reduce Alcohol ConsumptionCompletedNCT02158949Not applicableResults posted
• Medication Development in Alcoholism: Investigating PPAR AgonistsCompletedNCT02158273Phase 2Results posted
• Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol DependenceCompletedNCT02120365Phase 1/2Results posted
• Bilateral Prefrontal Modulation in AlcoholismCompletedNCT02091284Not applicableResults posted
• Ondansetron for Bipolar Disorder and Alcohol Use DisordersCompletedNCT02082678Phase 4Results posted
• Citicoline for Alcohol DependenceCompletedNCT02074735Phase 4Results posted
• A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol DependenceCompletedNCT02061293Phase 2Results posted
• Oxytocin Suppresses Substance Use Disorders Associated With Chronic StressCompletedNCT02058251Phase 1Results posted
• Development of Ivermectin for Alcohol Use DisordersCompletedNCT02046200Phase 1/2Results posted
• Relational Agent for Alcohol Screening and TreatmentCompletedNCT02030288Not applicableResults posted
• Naltrexone for Individuals of East Asian DescentCompletedNCT02026011Phase 2Results posted
• Efficacy and Safety of High Dose Baclofen for Alcohol DependenceCompletedNCT01980706Phase 2Results posted
• Preventing Alcohol Withdrawal With Oral BaclofenTerminatedNCT01937364Phase 2Results posted
• Harm Reduction With Pharmacotherapy (HaRP)CompletedNCT01932801Phase 2Results posted
• Neural Mechanisms of Change During the Treatment of Alcohol Use Disorders With PrazosinCompletedNCT01916941Not applicableResults posted
• Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness StudyCompletedNCT01908062Phase 3Results posted
• Examination of Zinc, S-adenosylmethionine, and Combination Therapy Versus Placebo in AlcoholicsCompletedNCT01899521Not applicableResults posted
• Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary CareCompletedNCT01893827Phase 4Results posted
• Retraining Attention to Treat Alcohol Dependence and Social AnxietyCompletedNCT01886716Not applicableResults posted
• Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol DependenceCompletedNCT01856712Phase 3Results posted
• Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol DependenceCompletedNCT01847469Phase 2Results posted
• Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy DrinkersCompletedNCT01779024Phase 2Results posted
• Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy DrinkersTerminatedNCT01764685Phase 2Results posted
• Valproate for Mood Swings and Alcohol Use Following Head InjuryCompletedNCT01760785Not applicableResults posted
• Dutasteride Treatment for the Reduction of Heavy Drinking in MenCompletedNCT01758523Phase 4Results posted
• Baclofen for Treating Anxiety and AlcoholismCompletedNCT01751386Phase 2Results posted
• A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSDCompletedNCT01749215Phase 4Results posted
• Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis CCompletedNCT01707030Not applicableResults posted
• Helping Families Help Veterans With PTSD and Alcohol Abuse: An RCT of VA-CRAFTCompletedNCT01678196Not applicableResults posted
• Citalopram Effects on Craving and Dopamine Receptor Availability in AlcoholicsCompletedNCT01657760Phase 1Results posted
• Computer-delivered Screening and Brief Intervention for Alcohol Use in PregnancyCompletedNCT01643044Phase 1Results posted
• Role of Proinflammatory Signaling in Alcohol CravingTerminatedNCT01631630Phase 2Results posted
• ABT-436 for Alcohol DependenceCompletedNCT01613014Phase 2Results posted
• Integrated Alcohol Disorder and PTSD TreatmentCompletedNCT01601067Phase 2Results posted
• Functional Neuroimaging of Alcoholism Vulnerability (PIT)CompletedNCT01585168Phase 2Results posted
• Contingency Management of Alcohol Abuse in the Severely Mentally ILLCompletedNCT01567943Not applicableResults posted
• Zonisamide for Heavy Drinkers With Bipolar DisorderTerminatedNCT01566370Phase 2Results posted
• Varenicline Treatment of Alcohol Dependence in SmokersCompletedNCT01553136Phase 2Results posted
• Medication Development in Alcoholism: Investigating Glucocorticoid AntagonistsCompletedNCT01548417Phase 2Results posted
• Screening to Augment Referral to Treatment- Project STARTCompletedNCT01539525Not applicableResults posted
• Effects and Therapeutic Potential of Psilocybin in Alcohol DependenceCompletedNCT01534494Phase 2Results posted
• Prazosin for Alcohol Dependence and Posttraumatic Stress DisorderCompletedNCT01518972Phase 2Results posted
• Risperidone and Desipramine in Alcohol Use and SchizophreniaCompletedNCT01411085Phase 2Results posted
• Mechanisms of Change, Motivation, and Treatment Outcome in Alcohol Dependence - Posttraumatic Stress DisorderCompletedNCT01409707Not applicableResults posted
• Topiramate for Alcohol Use in Posttraumatic Stress DisorderTerminatedNCT01408641Not applicableResults posted
• Varenicline Treatment for Active Alcoholic SmokersCompletedNCT01347112Phase 2/3Results posted
• Treatment Strategy for Alcohol Use Disorders in Veterans With TBICompletedNCT01342549Phase 3Results posted
• Placebo-Controlled Cross Over Trial of Chlorzoxazone IntakeCompletedNCT01342341Phase 4Results posted
• Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use DisordersCompletedNCT01338506Not applicableResults posted
• Vigabatrin for Cocaine and Alcohol DependenceTerminatedNCT01335867Phase 2Results posted
• Transcranial Direct Current Stimulation Over Dorsolateral Prefrontal Cortex in AlcoholismCompletedNCT01330394Phase 2Results posted
• Effects of Sulfasalazine on BOLD Response to Alcohol CuesCompletedNCT01312129Not applicableResults posted
• Sweet Preference and Alcohol CravingCompletedNCT01296646Phase 2Results posted
• Aripiprazole Effects on Alcohol Drinking and CravingCompletedNCT01292057Phase 3Results posted
• Dutasteride for the Reduction of Alcohol Use in Male DrinkersCompletedNCT01262287Phase 4Results posted
• Ondansetron, Alcohol Use, and Alcohol-Related Symptoms In HIV+ PersonsCompletedNCT01254877Phase 2Results posted
• Will Having Alcohol Treatment Improve Functioning?CompletedNCT01245647Phase 2Results posted
• Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^CompletedNCT01227980Phase 2Results posted
• ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)CompletedNCT01218997Phase 3Results posted
• ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®)CompletedNCT01218971Phase 3Results posted
• ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent AdultsCompletedNCT01218958Phase 3Results posted
• N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol DependenceCompletedNCT01214083Phase 2Results posted
• Effects of Omegas 3 and 6 on Alcohol DependenceCompletedNCT01211769Phase 3Results posted

← Alcoholism overview